Submitted by Anonymous (not verified) on 5 October 2026 - 16:31
Human medicines European public assessment report (EPAR): Byooviz, ranibizumab, Date of authorisation: 18/08/2021, Revision: 14, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Byooviz, ranibizumab, Date of authorisation: 18/08/2021, Revision: 14, Status: Authorised